Severe mycoplasma pneumonia in young children with Down syndrome

S L Orlicek1, M S Walker, T L Kuhls

  • 1Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City.

Clinical Pediatrics
|July 1, 1992
PubMed

Insights

Young children with Down syndrome may experience severe mycoplasma pneumonia due to immune issues. Physicians should consider Mycoplasma pneumoniae in Down syndrome patients presenting with pneumonia symptoms.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Down syndrome is associated with immune abnormalities, potentially increasing susceptibility to infections.
  • Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children.

Observation:

  • Three young children with Down syndrome presented with symptoms including fever, cough, wheezing, irritability, and tachypnea.
  • Chest radiographs revealed bilateral infiltrates, and all children developed respiratory distress requiring hospitalization.

Findings:

  • Laboratory studies indicated Mycoplasma pneumoniae as the likely cause of pneumonia in these children.
  • The severity of infection may be linked to immune dysregulation in Down syndrome.

Implications:

  • This case series suggests Mycoplasma pneumoniae should be considered in the differential diagnosis of pneumonia in young children with Down syndrome.
  • Early consideration of this pathogen may lead to timely diagnosis and appropriate management, potentially preventing severe outcomes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...